Sirnaomics (HKSE:02257) Valuation Rank

View and export this data going back to 2021. Start your Free Trial

What is Sirnaomics Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Sirnaomics Valuation Rank Related Terms

Thank you for viewing the detailed overview of Sirnaomics's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirnaomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirnaomics Ltd (HKSE:02257) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

V5Z:Germany

Address

No.218 Xinghu Street, Unit 415, A4 Building, Suzhou Industrial Park, Suzhou, CHN

Website

https://www.sirnaomics.com

Sirnaomics Ltd is a therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of drugs for indications with medical needs and large market opportunities. The Group's operations and non-current assets are located at the United States of America and the mainland of the People's Republic of China.

Executives

Poon Hung Fai	2101 Beneficial owner
Lu Yang	2101 Beneficial owner
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Dai Xiaochang	2201 Interest of corporation controlled by you
Yan Xia Ling	2202 Interest of your spouse
Ceng Yu	2201 Interest of corporation controlled by you
Li Jie	2201 Interest of corporation controlled by you
Li Lele	2202 Interest of your spouse
Shanghai Chongshi Enterprise Management Partnership(lp)	2101 Beneficial owner
Shenzhen Qianhai Rotating Boulder Fund Management Co.,ltd	2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Second Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Third Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you